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Sirtuins are a family of phylogenetically conserved nicotinamide adenine dinucleotide-dependent deacetylases that
have a firmly established role in aging. Using a simple Saccharomyces cerevisiae yeast heterochromatic derepression
assay, we tested a number of environmental chemicals to address the possibility that humans are exposed to sirtuin
inhibitors. Here we show that dihydrocoumarin (DHC), a compound found in Melilotus officinalis (sweet clover) that is
commonly added to food and cosmetics, disrupted heterochromatic silencing and inhibited yeast Sir2p as well as
human SIRT1 deacetylase activity. DHC exposure in the human TK6 lymphoblastoid cell line also caused concentration-
dependent increases in p53 acetylation and cytotoxicity. Flow cytometric analysis to detect annexin V binding to
phosphatidylserine demonstrated that DHC increased apoptosis more than 3-fold over controls. Thus, DHC inhibits
both yeast Sir2p and human SIRT1 deacetylases and increases p53 acetylation and apoptosis, a phenotype associated
with senescence and aging. These findings demonstrate that humans are potentially exposed to epigenetic toxicants
that inhibit sirtuin deacetylases.
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Introduction
Members of the silent information regulator 2 (SIR2) family
of genes encode highly conserved nicotinamide adenine
dinucleotide (NAD
þ)-dependent deacetylases present in
organisms from archaebacteria to eukaryotes [1]. In the yeast
Saccharomyces cerevisiae, Sir2p is a histone deacetylase required
for heterochromatic silencing at telomeres, ribosomal DNA,
and mating type loci [2]. The sirtuin family of deacetylases has
a ﬁrmly established role in aging [3]. Increased SIR2 activity,
mediated either by overexpression or through sirtuin-
activating compounds, increases longevity in S. cerevisiae [4],
Drosophila melanogaster [5], and Caenorhabditis elegans [5,6].
Conversely, SIR2 deletion reduces life span in S. cerevisiae by
30% [7], and Sir2p inhibition by nicotinamide mimics this
effect [8]. Seven apparent homologs of SIR2 (SIRT1–7) exist
in humans, with SIRT1 being the presumed Sir2p ortholog
due to sequence similarity [1]. Although the human sirtuin
deacetylases have a role in heterochromatin modiﬁcation,
they have mainly been identiﬁed to have nonhistone protein
targets [9].
SIRT1 has been identiﬁed to deacetylate p53 [10] as well as
a number of other proteins involved with the apoptotic
response [10–13]. The p53 tumor suppressor protein is often
referred to as the ‘‘guardian of the genome’’ due to its role in
cell cycle arrest, senescence, and apoptosis [14]. Lysine
acetylation (K320, K373, K382) increases p53 stability
[15,16], leading to the transcriptional activation of DNA
repair, cell cycle arrest, and proapoptotic genes. Because
SIRT1-mediated p53 deacetylation reverses these effects,
inhibition of this deacetylation step is hypothesized to
promote p53 stability and increase apoptosis levels. Apopto-
sis and p53 stabilization accompany SIRT1 down-regulation
[17], and SIRT1 inhibition by nicotinamide results in p53
hyperacetylation following DNA damage [10]. In addition,
SIRT1
 /  cells have been identiﬁed to be more susceptible to
killing by the genotoxic agents cisplatin and staurosporine
[18], indicating that SIRT1 abrogation may enhance p53
function. SIRT1-deﬁcient mice are observed to have devel-
opmental defects that are likely due to enhanced tumor
suppression by a hyperacetylated and stable p53 [19]. p53
activity appears to control a ﬁne balance between appro-
priate tumor suppression leading to cancer avoidance and
stem cell depletion leading to tissue senescence [20,21]. SIRT1
balances these processes.
The discovery that resveratrol, a chemical found in red
wine and other foods, increases life span in multiple
organisms through a mechanism that may involve the
activation of Sir2p [4,5] suggests that the diet and environ-
ment might also contain inhibitors of sirtuin enzymes. We
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exposed to an agent that disrupts one kind of epigenetically
heritable chromatin state, would mate and exhibit diploid
growth on minimal medium. We tested over 100 chemicals to
which humans are commonly exposed, including coumarins,
bioﬂavonoids, benzene metabolites, essential oils, and arsenic,
to address the possibility that these compounds could disrupt
heterochromatin repression. Here we show that dihydrocou-
marin (DHC), a compound found in Melilotus ofﬁcinalis (sweet
clover) that is widely used in the food and cosmetic industries
[22,23], tested positive in the yeast mating assay and was
identiﬁed to inhibit both Sir2p and SIRT1. Concentration-
dependent increases in cytotoxicity, apoptosis, and p53
acetylation were observed following DHC exposure in the
human TK6 lymphoblastoid cell line. These ﬁndings demon-
strate that humans are exposed to epigenetic toxicants that
inhibit sirtuin deacetylases.
Results
Development of a Screening Assay to Detect
Environmental Chemicals That Disrupt Heterochromatin
Silencing in S. cerevisiae
Haploid S. cerevisiae exists in two distinct mating types, a
and a, controlled by a single locus on Chromosome III, MAT.
Additionally, both a and a information are stored at the
cryptic mating loci HMLa and HMRa. These cryptic mating
loci are used for mating-type interconversion and are
silenced in part by Sir2p. Using a strain in which both HML
and HMR contain a information and a recessive mata1–1
allele, disruption of any protein required for silencing,
including Sir2p, either by chemical inhibition or mutation,
would cause a phenotypic switch from an a to an a mating
type. Mixing these cells with a strain of yeast that is MATa
HMRa HMLa would result in mating only if heterochromatin
silencing were inhibited. Mixing strains of these genotypes
with complementary auxotrophic markers provided a simple
test for agents that disrupt heterochromatic silencing, leading
to mating and subsequent growth on minimal medium
containing uracil. Using this technically simple indicator
assay, we tested over 100 environmental chemicals to which
humans are exposed (e.g., arsenic, benzene metabolites,
coumarins, bioﬂavonoids, and essential oils, listed in Table
S1, Supporting Information).
DHC and M. officinalis Oil Extract Derepresses
Heterochromatic Silencing in S. cerevisiae
DHC (CAS# 119–84–6) from two independent sources
derepressed heterochromatic gene silencing in the yeast S.
cerevisiae mating assay (Figure 1). Oil extracts from M.
ofﬁcinalis, a common ﬂowering plant that contains small
amounts of DHC, also tested as a weak positive in the assay
(data not shown). Colony growth following DHC exposure
demonstrated a dose-response relationship at micromolar
levels that was similar to the level of heterochromatin
derepression observed with the established Sir2p inhibitor
splitomicin (Figures 1B and 1C).
DHC Is a Sir2p Inhibitor
The inhibition of heterochromatic silencing by DHC at
levels similar to those observed with splitomicin suggested
that it may be a Sir2p inhibitor; further experiments,
however, were necessary to test whether Sir2p was the target.
To this end, we employed a plasmid under a gal promoter
that overexpresses SIR2 and produces a lethal phenotype in
the presence of galactose [24]. Addition of 750 lM DHC
partially suppressed the Sir2p-induced lethality in galactose,
but had no deleterious effect in glucose (Figure 2), thus
pinpointing Sir2p as the target of DHC. Addition of a lower
concentration of DHC (500 lM DHC) also reversed the lethal
Figure 1. Effect of DHC on Heterochromatin Silencing in S. cerevisiae at
the HMR or HML Loci
(A) DMSO negative control, 1 M nicotinamide positive control, and 50
mM DHC.
(B and C) DHC and splitomicin, respectively, cause dose-dependent
increases in heterochromatin silencing and colony formation.
DOI: 10.1371/journal.pgen.0010077.g001
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Synopsis
The effects of chronic low-dose human exposure to environmental
chemicals are difficult to study and poorly understood. Chemicals
are routinely tested for the ability to induce DNA mutations, cause
chromosome damage, or produce cell death, but are rarely tested
for their ability to cause epigenetic changes, which can influence the
behavior of a cell without directly changing the DNA sequence.
Epigenetic changes have become the focus of intense research in an
attempt to understand the mechanisms by which they function. The
Sir2 family of deacetylases is one class of proteins that controls some
epigenetic processes and, interestingly, has been implicated in
extending the longevity of several organisms. Here the authors
describe a novel assay based upon yeast Sir2p function to screen
environmental chemicals for their ability to alter epigenetic
silencing. From screening a relatively small number of agents, the
authors found that dihydrocoumarin, a natural compound found in
Melilotus officinalis (sweet clover) that is synthetically manufactured
and frequently added to both food and cosmetics, disrupted
epigenetic processes in the yeast Saccharomyces cerevisiae. Dihy-
drocoumarin also inhibited several human Sir2 family deacetylases
(SIRT1 and SIRT2) and, when added to cells in culture, increased p53
tumor suppressor protein acetylation and caused elevated levels of
apoptosis. The present study suggests that humans are exposed to a
number of environmental chemicals that may be classified as
epigenetic toxicants.SIR2 phenotype (data not shown). A recent report using a
yeast telomeric reporter assay to analyze splitomicin analogs
[25] support our ﬁnding that DHC is a yeast Sir2p inhibitor.
DHC Inhibits Human SIRT1 and SIRT2
We tested whether DHC could inhibit the human NAD
þ-
dependent deacetylase SIRT1 and observed that DHC
induced a concentration-dependent inhibition of SIRT1
(IC50 of 208 lM) in an in vitro enzymatic assay (Figure 3A).
A decrease in SIRT1 deacetylase activity was observed even at
micromolar doses (85 6 5.8 and 73 6 13.7% activity at 1.6 lM
and 8 lM, respectively). The microtubule SIRT2 [26]
deacetylase was also inhibited with a similar dose dependency
(Figure 3B).
DHC Increases p53 Acetylation, Cytotoxicity, and
Apoptosis Levels
Experiments with the human TK6 lymphoblastoid cell line
further addressed DHC-mediated SIRT1 inhibition. Immu-
noblot analysis demonstrated that both p53 acetylation and
cytotoxicity increased in a dose-dependent manner following
DHC exposure (Figure 4A and 4B). Flow cytometric analysis
measuring annexin V binding to phosphatidylserine demon-
strated that apoptosis levels increased more than 3-fold
following DHC exposure (Figure 4C and 4D).
Discussion
Epigenetic drift is hypothesized to occur, in part, through
exposure to environmental and dietary compounds that
affect the processes responsible for the proper maintenance
of the proteome and epigenome [27,28]. The recent discovery
that signiﬁcant differences in epigenetic markers exist in
monozygotic twins who lived different lifestyles and spent
little time together supports this environmentally driven
epigenetic drift hypothesis [29]. Additionally, the ﬁnding that
methoxychlor, a common DDT substitute used to control
mosquitoes, and vinclozolin, a broadly used fungicide applied
in the wine industry [30], caused transgenerational epigenetic
effects up to the F4 generation [31] indicates that humans are
likely exposed to epigenetic toxicants causing epigenetic drift
on a regular basis. These are intriguing ﬁndings that raise the
question of whether the diet and environment contain
epigenetic toxicants that may also inhibit the sirtuin
deacetylases.
We have designed a yeast mating assay to identify
environmental chemicals that inhibit heterochromatic re-
pression in S. cerevisiae to address the possibility that humans
are exposed to epigenetic toxicants that inhibit sirtuin
deacetylases. After screening more than 100 environmental
chemicals to which humans are exposed, including coumar-
ins, bioﬂavonoids, benzene metabolites, and arsenic, we
identiﬁed that DHC disrupted heterochromatic repression
(see Figure 1A). Further analyses demonstrated that DHC-
mediated heterochromatic derepression caused yeast colony
Figure 2. DHC Reverses the Lethal Phenotype of Galactose-Induced
Plasmid SIR2 Overexpression
Two-fold yeast serial dilutions were used for this assay. Growth is
observed on 0.1% DMSO and 750 lM DHC in dextrose medium. The
lethal SIR2 phenotype is observed on the 0.1% DMSO galactose medium
but is partially reversed on the 750 lM DHC galactose medium.
DOI: 10.1371/journal.pgen.0010077.g002
Figure 3. DHC Inhibits Human NAD
þ-Dependent Deacetylases In Vitro
(A) Dose-dependent inhibition of SIRT1 (y ¼  19.98x þ 96.431).
(B) Dose-dependent inhibition of SIRT2 (y ¼ 20.79xþ 101.34). Averages
6 standard error from two separate experiments are shown.
DOI: 10.1371/journal.pgen.0010077.g003
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similar to splitomicin (Figure 1B and 1C). Splitomicin is an
established Sir2p inhibitor [32] with a structure similar to
DHC, thus it was likely that DHC-mediated heterochromatic
derepression in the mating assay was due to Sir2p inhibition.
Further experiments with an overexpressing SIR2-induced
death phenotype were conducted to identify if Sir2p was the
target of DHC. DHC-mediated reversal of the SIR2 overex-
pressed death phenotype (Figure 2) indicated that DHC is a
Sir2p inhibitor and that this inhibition was responsible for
the heterochromatic derepression observed in the mating
assay. DHC thus joins a short list of established Sir2p
inhibitors that includes nicotinamide, splitomicin, and
sirtinol [33].
The identiﬁcation that DHC is a Sir2p inhibitor is of
particular interest because it is a natural component of M.
ofﬁcinalis and is synthetically manufactured for use as a
common fragrance in perfumes, cosmetics, lotions, soaps, and
as a ﬂavoring agent in beverages and chewing gum [23,34].
DHC is present at concentrations above 100 ppm (670 lM) in
gelatins, puddings, soft candy, frozen dairy products, and
baked goods [22]. Due to the potential DHC exposure to
humans, we tested whether it could also inhibit human sirtuin
deacetylases and identiﬁed that DHC inhibited both SIRT1
and SIRT2 deacetylases in vitro (Figure 3A and 3B). We also
measured SIRT3 deacetylase activity but did not identify it to
be affected by DHC (data not shown). It is only recently that
the cellular function of the human sirtuin deacetylases has
begun to be revealed. Because there are at least seven human
sirtuins [1], it is expected that the substrates and functions of
each will vary. SIRT2 is a cytoplasmic protein identiﬁed to be
a microtubule deacetylase [26], an observation that may help
explain its requirement for proper progression through
mitosis [35]. SIRT1 has been identiﬁed to deacetylate a
variety of nuclear substrates [9], including several that are
transcription factors regulating differentiation and develop-
ment or proteins involved in the apoptotic response,
including FOXO [12,36], ku70 [11], p53 [10], and MEF2 [37].
Although SIRT1 has been identiﬁed to have mostly nonhi-
stone targets, there is growing evidence to indicate that
SIRT1 interacts with a number of transcription factors with
results that may mimic epigenetic modiﬁcations. How SIRT1
inhibitors can affect these processes is just beginning to be
understood.
Because SIRT1 has been identiﬁed to deactivate p53
through deacetylation, experiments in the human TK6
lymphoblastoid cell line were conducted to identify if DHC
could induce a phenotype consistent with SIRT1 inhibition
and p53 activation. DHC was identiﬁed to increase p53
acetylation, cytotoxicity, and apoptosis levels in vitro (Figure
4). In addition, DHC enhanced cell killing to etoposide in
both the TK6 human lymphoblastoid and human embryonic
kidney 293 cell lines (data not shown), data compatible with
the observation that SIRT1
 /  cells are more susceptible to
killing by genotoxic agents [18]. Previous in vivo and in vitro
studies have demonstrated that DHC is not a mutagen,
clastogen, or aneugen [34], suggesting that it is unlikely that
DHC is stabilizing p53 and increasing cytotoxicity and
apoptosis through a genotoxic mechanism. Rather, these data
are consistent with the phenotypes of SIRT1 compromised
cells [10,17] and support the hypothesis that DHC-mediated
SIRT1 inhibition enhances p53 stabilization and increases
apoptosis. Increasing tumor suppression and the suscepti-
bility of a cell to undergo apoptosis, however, cannot solely be
viewed in a beneﬁcial chemotherapeutic light, particularly in
those cases where exposure to an apoptosis-inducing agent
may be widespread. The deleterious effects of a hyperactive
p53 have been demonstrated in a transgenic mouse model
that displayed a shortened life span and a variety of early
aging-associated phenotypes [38]. It is hypothesized that
increased levels of apoptosis cause a rapid depletion of stem
cells, leading to premature tissue senescence [20,21], possibly
decreasing longevity. Increasing p53 tumor suppression
through inhibition of SIRT1 may tip the cell-survival balance
toward apoptosis in a cell that would otherwise not undergo
programmed cell death. It is interesting to speculate whether
sirtuin deacetylases, which have a role in regulating longevity
in a variety of organisms, may also regulate longevity in
mammals through the control of apoptosis. Further work is
clearly needed to address the possibility that enhanced
apoptosis through chemical-mediated inhibition of SIRT1
can increase tissue senescence and affect longevity.
Our ﬁnding that the common ﬂavoring agent DHC inhibits
sirtuin deacetylases linked to aging is potentially worrisome.
SIRT1 inhibition may lead to epigenetic alterations as well as
possible stem cell depletion and early tissue senescence due
to increased levels of apoptosis. While no compounds to our
knowledge are currently classiﬁed as ‘‘senescegens,’’ it is
possible that a number of environmental chemicals can
Figure 4. DHC Increases p53 Acetylation, Cytotoxicity, and Apoptosis in
the TK6 Cell Line
(A) DHC increases p53 lysine 373 and 382 acetylation in a dose-
dependent manner in the TK6 cell line following a 24-h exposure period.
The immunoblot is representative of three separate experiments.
(B) DHC increases cytotoxicity in a dose-dependent manner following a
24-h exposure to DHC. The average 6 standard error for each of three
experiments is shown.
(C) A 5-mM dose of DHC increases apoptosis at the 6-h time point in the
TK6 cell line. A combination of annexin V fluorescein isothiocyanate and
propidium iodide staining was used to discriminate among apoptotic
(lower-right box) and necrotic (upper-right box) cells. Figures are
representative of three separate experiments.
(D) DHC increases apoptosis in a dose-dependent manner in the TK6 cell
line at the 6-h time point. The average 6 standard error for three
experiments is shown.
DOI: 10.1371/journal.pgen.0010077.g004
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demonstrates that a more extensive screening of dietary and
environmental chemicals is needed to identify other epige-
netic toxicants to which humans are commonly exposed.
Materials and Methods
Yeast mating assay. JRY075 (MATa, HMLa, HMRa, ade6, met, his4,
leu2, and ura3) and JRY80 (mata1–1, HMLa, HMRa, leu1, ura3, and ade2)
yeast strains [39] were combined in liquid rich-medium (YPD), and 50
ll of the mixture was spread onto YM plates containing 30 lg/ml
uracil. Chemicals (Sigma, St. Louis, Missouri, United States; Indoﬁne,
Hillsborough, New Jersey, United States) were dissolved in DMSO and
added to the YM uracilþ plates at 50 mM concentrations, whereas
essential oils and plant oil extracts (Yerba Buena, Woodside,
California, United States; Lhasa Kharnak, Berkeley, California,
United States; and Nature’s Apothecary, Bloomingdale, Illinois,
United States) were added directly to the plates. Plates were
incubated for at least 72 h at room temperature to allow for diploid
growth on minimal medium containing uracil. Nicotinamide (1 M)
and DMSO were used as the positive and solvent controls,
respectively, for all experiments. Yeast colony DHC and splitomicin
dose-response experiments were conducted to compare the ability of
DHC to disrupt heterochromatin repression with an established
Sir2p inhibitor. Varying doses (1 through 25 lM) of DHC and
splitomicin were added directly to the YM and uracil medium.
Inhibition of the SIR2-induced death phenotype. The yeast strain
YSH278 and the galactose-induced SIR2 pSS3 plasmid were the kind
gifts of Scott Holmes. The yeast strain YSH278 was transformed with
the pSS3 plasmid containing galactose-inducible alleles and grown
overnight in rafﬁnose medium lacking leucine. Sets of 2-fold serial
dilutions from these cultures were spotted onto YM glucose medium
lacking leucine ( LEU) and on galactose medium lacking leucine
( LEU GAL). Both the dextrose and galactose plates contained 750
lM DHC or 0.1% DMSO as a solvent control. Plates were incubated
for at least 72 h at room temperature.
SIRT1 and SIRT2 deacetylase assays. The histone deacetylation
assay with recombinant SIRT1 and SIRT2 was performed, as
described previously [40], using a [
3H] acetylated histone H4 peptide.
Cell culture and immunoblot analysis. The human TK6 lympho-
blastoid cell line (ATCC) was maintained in RPMI1640 medium
(GIBCO, San Diego, California, United States) containing 10% FBS
(Omega Scientiﬁc, Tarzana, California, United States) and 1%
penicillin and streptomycin (Omega Scientiﬁc) under standard
conditions. TK6 cells were exposed to 0.1% DMSO and 1, 2, 3, 4,
and 5 mM DHC for 24 h at a concentration of 3.5310
5–5310
5. Total
cell lysates were collected from 1.5310
6–2310
6 cells using 100 llo f
radioimmunoprecipitation assay (RIPA) lysis buffer. Protein concen-
trations were determined by the Bradford assay (Bio-Rad, Hercules,
California, United States). Equal protein amounts were resolved by
PAGE, transferred onto nitrocellulose membranes, and imunoblotted
for lysine 372 and 383 acetylated p53 (Upstate, Charlottesville,
Virginia, United States). Protein was visualized using the ECL method
per manufacturer’s protocol (Amersham Biosciences, Little Chalfont,
United Kingdom). Film (Kodak BioMax XAR; Eastman Kodak
Corporation, Rochester, New York, United States) was exposed and
developed using the Konica SRX-101 developer (Konica Minolta
Medical Imaging USA, Wayne, New Jersey, United States).
Cellular cytotoxicity and apoptosis assays. Cellular cytotoxicity for
the aforementioned TK6 DHC experiments was conducted using the
Trypan blue exclusion assay. A minimum of 200 cells were analyzed
for each dose and experiment. Annexin V apoptosis assays were
performed in three additional experiments in which TK6 cells were
exposed to 0.1% DMSO and 1, 2, 3, 4, and 5 mM DHC for 6 h. TK6 cells
were prepared for ﬂow cytometric annexin V analysis following the
manufacturer’s protocol (BD Biosciences Pharmingen, San Diego,
California, United States), except that 5 ll of 1 mg/ml propidium
iodide (PI) was used. At least 10,000 TK6 cells were analyzed on a
Beckman Coulter EPICS XL-MCL ﬂow cytometer (Fullerton, Califor-
nia, United States) using System II software for each experiment. Live
cells were gated and analyzed for annexin V FITC and PI staining.
Supporting Information
Table S1. List of Chemicals and Essential Oils Tested for Hetero-
chromatic Repression in the Yeast Mating Assay
Found at DOI: 10.1371/journal.pgen.0010077.st001 (32 KB DOC).
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